| 14th Dec 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 14th Dec 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 14th Dec 2021 7:01 am |
RNS |
Subscription to raise £1.65 million |
| 14th Dec 2021 7:00 am |
RNS |
Half year Report |
| 25th Nov 2021 7:00 am |
RNS |
Positive pre-clinical data on NXP002 |
| 17th Nov 2021 9:34 am |
RNS |
Holding(s) in Company |
| 12th Nov 2021 7:00 am |
RNS |
NXP004 patent application filing |
| 9th Nov 2021 7:00 am |
RNS |
Directorate Change |
| 4th Oct 2021 2:01 pm |
RNS |
Price Monitoring Extension |
| 16th Sep 2021 2:14 pm |
RNS |
Director/PDMR Shareholding - Replacement |
| 16th Sep 2021 12:47 pm |
RNS |
Director/PDMR Shareholding |
| 13th Sep 2021 7:00 am |
RNS |
Licensing agreement with Oxilio for NXP001 |
| 24th Aug 2021 11:57 am |
RNS |
Result of AGM |
| 23rd Jul 2021 1:35 pm |
RNS |
Posting of Annual Report and Notice of AGM |
| 22nd Jul 2021 7:00 am |
RNS |
Letter to shareholders re: Dr Anne Brindley |
| 21st Jul 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 21st Jul 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 21st Jul 2021 7:00 am |
RNS |
Directorate Change |
| 15th Jul 2021 7:00 am |
RNS |
Final results for the year ended 31 March 2021 |
| 10th Jun 2021 9:25 am |
RNS |
Holding(s) in Company |
| 7th Jun 2021 7:00 am |
RNS |
Notice of Allowance of Patent in US |
| 1st Jun 2021 7:00 am |
RNS |
Project update - Progress on NXP002 and NXP004 |
| 24th May 2021 7:00 am |
RNS |
Directorate Changes |
| 12th May 2021 11:35 am |
RNS |
Holding(s) in Company |
| 11th May 2021 1:51 pm |
RNS |
Holding(s) in Company |
| 22nd Apr 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 22nd Apr 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 8th Apr 2021 3:30 pm |
RNS |
Correction: Holding(s) in Company |
| 8th Apr 2021 11:54 am |
RNS |
Holding(s) in Company |
| 6th Apr 2021 10:38 am |
RNS |
Holding(s) in Company |
| 30th Mar 2021 5:14 pm |
RNS |
Holding(s) in Company |
| 29th Mar 2021 11:27 am |
RNS |
Result of General Meeting and Total Voting Rights |
| 22nd Mar 2021 7:00 am |
RNS |
NXP001 (Oncology) - Exercise of Option by Oxilio |
| 19th Mar 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 19th Mar 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 19th Mar 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 19th Mar 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 19th Mar 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 19th Mar 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 11th Mar 2021 7:00 am |
RNS |
Initiation of research by Allenby Capital |
